Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marcus Ditschkowski"'
Autor:
Marcus Ditschkowski, Mahmoud Aljurf, Juan Carlos Hernández-Boluda, Eibhlin Conneally, Donal P. McLornan, Marie Robin, Tomasz Czerw, Patrick Hayden, Nicholas C.P. Cross, Ibrahim Yakoub-Agha, H. Joachim Deeg, Nicola Polverelli, Mufaddal T. Moonim
Publikováno v:
Leukemia. 35:2445-2459
Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non-relapse mortality rates remain significant. Relapse rates vary between 15 and 25
Autor:
Donal P. McLornan, Juan Carlos Hernandez-Boluda, Tomasz Czerw, Nicholas Cross, H. Joachim Deeg, Marcus Ditschkowski, Mufaddal T. Moonim, Nicola Polverelli, Marie Robin, Mahmoud Aljurf, Eibhlin Conneally, Patrick Hayden, Ibrahim Yakoub-Agha
During the Editorial process, the author name of Juan Carlos Hernández-Boluda to Hernández Boluda. The original article was updated to correct this. Korrektur zu: 10.1038/s41375-021-01294-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bbd87902741cbb306ada3dcc3c64129
https://hdl.handle.net/11379/569812
https://hdl.handle.net/11379/569812
Autor:
Haefaa Alchalby, Francisco Cervantes, Francesco Passamonti, Marcus Ditschkowski, Bart L. Scott, Dietrich W. Beelen, Mario Cazzola, Toni Giorgino, Nicolaus Kröger, Enrica Morra, Arturo Pereira, Margherita Maffioli, Alessandro M. Vannucchi, Tatjana Zabelina, H. Joachim Deeg
Publikováno v:
Blood (Online) 124 (2014): 633.
info:cnr-pdr/source/autori:Kröger, N.;Giorgino, T.;Scott, B.L.;Ditschkowski, M.;Alchalby, H.;Cervantes, F.;Vannucchi, A.V.;Cazzola, M.;Morra, E.;Zabelina, T.;Maffioli, M.;Pereira, A.;Beelen, D.;Deeg, H.J.;Passamonti, F./titolo:Survival of Allogeneic Stem Cell Transplantation Vs Conventional Therapies per DIPSS Stratification in Patients with Primary Myelofibrosis Younger Than 65 Years: A Retrospective Analysis on 673 Patients/doi:/rivista:Blood (Online)/anno:2014/pagina_da:633/pagina_a:/intervallo_pagine:633/volume:124
info:cnr-pdr/source/autori:Kröger, N.;Giorgino, T.;Scott, B.L.;Ditschkowski, M.;Alchalby, H.;Cervantes, F.;Vannucchi, A.V.;Cazzola, M.;Morra, E.;Zabelina, T.;Maffioli, M.;Pereira, A.;Beelen, D.;Deeg, H.J.;Passamonti, F./titolo:Survival of Allogeneic Stem Cell Transplantation Vs Conventional Therapies per DIPSS Stratification in Patients with Primary Myelofibrosis Younger Than 65 Years: A Retrospective Analysis on 673 Patients/doi:/rivista:Blood (Online)/anno:2014/pagina_da:633/pagina_a:/intervallo_pagine:633/volume:124
Introduction Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm with a high risk of clonal evolution and mortality. Allogeneic stem cell transplantation (ASCT) is currently the only curative treatment approach for myelofibrosis. Due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::790306f9ad882f87f145be7356980242
https://publications.cnr.it/doc/299299
https://publications.cnr.it/doc/299299